BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10534767)

  • 1. Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways.
    Yeh JJ; Marsh DJ; Zedenius J; Dwight T; Delbridge L; Robinson BG; Eng C
    Genes Chromosomes Cancer; 1999 Dec; 26(4):322-8. PubMed ID: 10534767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors.
    Halachmi N; Halachmi S; Evron E; Cairns P; Okami K; Saji M; Westra WH; Zeiger MA; Jen J; Sidransky D
    Genes Chromosomes Cancer; 1998 Nov; 23(3):239-43. PubMed ID: 9790504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas.
    Marsh DJ; Zheng Z; Zedenius J; Kremer H; Padberg GW; Larsson C; Longy M; Eng C
    Cancer Res; 1997 Feb; 57(3):500-3. PubMed ID: 9012481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
    Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors.
    Zedenius J; Wallin G; Svensson A; Bovèe J; Höög A; Bäckdahl M; Larsson C
    Hum Genet; 1996 Mar; 97(3):299-303. PubMed ID: 8786068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
    Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
    Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.
    Marsh DJ; Dahia PL; Coulon V; Zheng Z; Dorion-Bonnet F; Call KM; Little R; Lin AY; Eeles RA; Goldstein AM; Hodgson SV; Richardson AL; Robinson BG; Weber HC; Longy M; Eng C
    Genes Chromosomes Cancer; 1998 Jan; 21(1):61-9. PubMed ID: 9443042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.
    Ward LS; Brenta G; Medvedovic M; Fagin JA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):525-30. PubMed ID: 9467569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic follicular thyroid tumors show loss of a 200-kb region in 11q13 without evidence for mutations in the MEN1 gene.
    Nord B; Larsson C; Wong FK; Wallin G; Teh BT; Zedenius J
    Genes Chromosomes Cancer; 1999 Sep; 26(1):35-9. PubMed ID: 10441003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
    Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas.
    Sarquis MS; Weber F; Shen L; Broelsch CE; Jhiang SM; Zedenius J; Frilling A; Eng C
    J Clin Endocrinol Metab; 2006 Jan; 91(1):262-9. PubMed ID: 16249278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
    Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
    Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
    Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
    Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss.
    Tung WS; Shevlin DW; Kaleem Z; Tribune DJ; Wells SA; Goodfellow PJ
    Genes Chromosomes Cancer; 1997 May; 19(1):43-51. PubMed ID: 9135994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelotyping of follicular thyroid tumors.
    Zedenius J; Wallin G; Svensson A; Grimelius L; Höög A; Lundell G; Bäckdahl M; Larsson C
    Hum Genet; 1995 Jul; 96(1):27-32. PubMed ID: 7607650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors.
    Gimm O; Perren A; Weng LP; Marsh DJ; Yeh JJ; Ziebold U; Gil E; Hinze R; Delbridge L; Lees JA; Mutter GL; Robinson BG; Komminoth P; Dralle H; Eng C
    Am J Pathol; 2000 May; 156(5):1693-700. PubMed ID: 10793080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity in follicular and papillary thyroid carcinomas.
    Rodrigues-Serpa A; Catarino A; Soares J
    Cancer Genet Cytogenet; 2003 Feb; 141(1):26-31. PubMed ID: 12581895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions.
    Trovato M; Ulivieri A; Dominici R; Ruggeri RM; Vitarelli E; Benvenga S; Barresi G; Trimarchi F; Brunetti E; Vecchione A; Andreoli M; Sciacchitano S
    Endocr Relat Cancer; 2004 Jun; 11(2):365-76. PubMed ID: 15163311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.